NCT00748982View on ClinicalTrials.gov

Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Left Ventricle Function
Interventions
DRUG

AZD1305

iv single infusion: initial iv loading dose which will be followed by a maintenance dose given for a maximum of 90 minutes

DRUG

Placebo

iv single infusion: initial iv loading dose which will be followed by a maintenance dose given for a maximum of 90 minutes

Trial Locations (1)

Unknown

Research Site, Gothenburg

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY